Ingredion Incorporated (INGR) SEC Filings & Earnings Calls
EquiReason read 23 Ingredion Incorporated SEC filings in the last 12 months. Latest: 8-K on 2026-08-20 — Reported a director or officer change (departure, election, appointment or pay arrangement).
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 6.0B
- P/E TTM
- 10.4
- Dividend yield
- 3.5%
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
20 Aug 20268-K · 5.02Reported a director or officer change (departure, election, appointment or pay arrangement)open
Risks flagged
Leadership transition risk is low; no disagreement or financial impact noted.
“No disagreement with company operations, policies, or practices.”
7 Aug 202610-QIngredion announced a $3.5B all-cash acquisition of Tate & Lyle, expected to close in H2 2027, to create a global specialty ingredients leader.acquisitionopen
Figures in the filing · each found in the filing text
| Net sales · Q2-2026 | $1.85B | +1% y/y |
| Net income attributable to Ingredion · Q2-2026 | $114M | -42% y/y |
| Gross profit margin · Q2-2026 | 23.0% | |
| Operating income · H1-2026 | $391M | -29% y/y |
| T&HS net sales · Texture & Healthful Solutions · Q2-2026 | $627M | +5% y/y |
| F&II–LATAM net sales · Food & Industrial Ingredients – LATAM · Q2-2026 | $611M | +3% y/y |
| F&II–U.S./Canada net sales · Food & Industrial Ingredients – U.S./Canada · Q2-2026 | $488M | -7% y/y |
| Total debt outstanding · 2026-06-30 | $1.80B |
Risks flagged
Acquisition integration risk
“The pending acquisition of Tate & Lyle is subject to regulatory approvals and other conditions; completion expected in H2 2027.”
Operational disruption
“Cost of sales increased due to the thermal event at our Argo facility, impacting gross margin.”
Foreign exchange risk
“Financing costs increased due to $47 million of acquisition-related foreign exchange hedging losses.”
4 Aug 20268-K · 2.02Adjusted Diluted EPS $2.82 (-2% y/y); Reported Diluted EPS $1.78 (-40% y/y); Net Sales $1.85B (+1% y/y); Guidance: Adjusted EPS $10.30-$10.90earningsopen
Figures in the filing · each found in the filing text
| Adjusted Diluted EPS · Q2-2026 | $2.82 | -2% y/y |
| Reported Diluted EPS · Q2-2026 | $1.78 | -41% y/y |
| Net Sales · Q2-2026 | $1.85B | +1% y/y |
| Adjusted Operating Income · Q2-2026 | $258M | -6% y/y |
| Texture & Healthful Solutions Net Sales · Texture & Healthful Solutions · Q2-2026 | $627M | +5% y/y |
| Texture & Healthful Solutions Operating Income · Texture & Healthful Solutions · Q2-2026 | $117M | +5% y/y |
| Food & Industrial Ingredients – LATAM Net Sales · Food & Industrial Ingredients – LATAM · Q2-2026 | $611M | +3% y/y |
| Food & Industrial Ingredients – LATAM Operating Income · Food & Industrial Ingredients – LATAM · Q2-2026 | $118M | -7% y/y |
Guidance
Adjusted EPS $10.30-$10.90
Reaffirmed full-year adjusted EPS guidance; T&HS volume growth continues; pending acquisition adds strategic optionality.
Risks flagged
Foreign exchange headwinds and macroeconomic pressures in LATAM.
“We also successfully navigated foreign exchange headwinds and macroeconomic pressures.” · word for word
Unfavorable price mix and higher tapioca costs impacting margins.
“partially offset by unfavorable price mix and higher tapioca costs.” · word for word
28 Jul 20268-K · 7.01Ingredion announced that Tate & Lyle shareholders approved the all-cash acquisition. Completion expected in H2 2027, subject to antitrust and court approval.acquisitionopen
Risks flagged
Antitrust conditions and court sanction still required; deal completion risk.
“subject to the satisfaction or waiver of other conditions, including material antitrust conditions and sanction of the Scheme by the Court.”
6 Jul 20268-K · 7.01Ingredion provides update on recommended cash acquisition of Tate & Lyle; Scheme Document published; Court Meeting and General Meeting scheduled for July 28, 2026.acquisitionopen
Risks flagged
Acquisition subject to shareholder approval and court sanction; no guarantee of completion.
“Scheme requires approval by shareholders and sanction by High Court.”
25 Jun 20268-K · 1.01, 2.03Ingredion entered a Delayed Draw Term Loan Agreement with JPMorgan as administrative agent, creating a direct financial obligation. No dollar amount stated.open
Risks flagged
Increased leverage from acquisition financing; financial covenants include max leverage ratio 3.5x (4.0x post-acquisition).
“Max leverage ratio 3.5 to 1.0, increased to 4.0 for four quarters after material acquisition.”
9 Jun 20268-K · 1.01, 2.03, 7.01Ingredion announced a recommended cash offer for all shares of Tate & Lyle PLC, entering a bridge loan agreement to finance the acquisition. The deal is structured under UK Takeover Code Rule 2.7.acquisitionopen
Risks flagged
Acquisition subject to shareholder and regulatory approvals; long stop date June 2028.
“Conditions include Scheme approval, Court sanction, antitrust clearances.”
8 May 202610-QNet sales $1.79B (-1% y/y); Operating income $203M (-26% y/y); Gross profit margin 22; Guidance: capital investment commitments $400M-$440M for remainder of 2026open
Figures in the filing · each found in the filing text
| Net sales · Q1-2026 | $1.79B | -1% y/y |
| Operating income · Q1-2026 | $203M | -26% y/y |
| Gross profit margin · Q1-2026 | 22.0% | |
| Net income attributable to Ingredion · Q1-2026 | $142M | -28% y/y |
| T&HS net sales · T&HS · Q1-2026 | $617M | +2% y/y |
| F&II-LATAM net sales · F&II-LATAM · Q1-2026 | $579M | +1% y/y |
| F&II-U.S./Canada net sales · F&II-U.S./Canada · Q1-2026 | $475M | -9% y/y |
| Operating cash flow · Q1-2026 | $33M | -57% y/y |
| Capital expenditures · Q1-2026 | $110M | +20% y/y |
| Total debt outstanding · 2026-03-31 | $1.80B |
Guidance
capital investment commitments $400M-$440M for remainder of 2026
No explicit revenue guidance, but capex guidance indicates continued investment. Demand signals mixed with T&HS growth offset by U.S./Canada decline.
Risks flagged
Production disruption at Argo facility
“F&II–U.S./Canada operating income decreased 63 percent primarily from production challenges at our Argo facility.” · word for word
Volume decline and margin compression
“Gross profit margin decreased to 22 percent from 26 percent due to lower fixed cost absorption from lower volumes.” · word for word
Mexico transactional currency impact
“F&II–LATAM operating income decreased 9 percent driven primarily by Mexico transactional currency impacts.” · word for word
5 May 20268-K · 2.05, 2.06Approved costs associated with restructuring, layoffs, or exit activities; recorded a material asset impairment, writing down significant valueopen
Risks flagged
Restructuring charges may impact near-term earnings.
“Pre-tax non-recurring charges of ~$43M, majority in Q2 2026.”
5 May 20268-K · 2.02Ingredion reported Q1 2026 earnings miss: adjusted EPS $2.34 vs $2.97, operating income down 22%. Guidance cut: adjusted EPS range $10.45-$11.15 (from prior). Argo facility operational challenges drove weakness.earningsopen
Figures in the filing · each found in the filing text
| Net sales · Q1-2026 | $1.79B | -1% y/y |
| Reported operating income · Q1-2026 | $203M | -26% y/y |
| Adjusted operating income · Q1-2026 | $212M | -22% y/y |
| Reported diluted EPS · Q1-2026 | $2.22 | -26% y/y |
| Adjusted diluted EPS · Q1-2026 | $2.34 | -21% y/y |
| T&HS net sales · Texture & Healthful Solutions · Q1-2026 | $617M | +2% y/y |
| T&HS segment operating income · Texture & Healthful Solutions · Q1-2026 | $100M | +1% y/y |
| F&II-LATAM net sales · Food & Industrial Ingredients – LATAM · Q1-2026 | $579M | +1% y/y |
| F&II-LATAM segment operating income · Food & Industrial Ingredients – LATAM · Q1-2026 | $115M | -9% y/y |
| F&II-U.S./CAN net sales · Food & Industrial Ingredients – U.S./CAN · Q1-2026 | $475M | -9% y/y |
Guidance
FY2026 reported EPS $9.60-$10.30; adjusted EPS $10.45-$11.15 (from prior $10.45-$11.15 implied by Q1 miss)
Full-year guidance adjusted downward due to operational challenges and softer demand.
Risks flagged
Operational challenges at Argo facility causing significant earnings impact.
“a longer-than-expected recovery at our Argo facility negatively impacted results during the quarter” · word for word
Macroeconomic uncertainty and foreign exchange headwinds in LATAM.
“absorbing the year-over-year impact of Mexican foreign exchange headwinds” · word for word
25 Mar 20268-K · 5.02Reported a director or officer change (departure, election, appointment or pay arrangement)open
Risks flagged
CFO transition risk; interim appointment may signal uncertainty
“Interim CFO appointment following resignation of prior CFO”
23 Mar 20268-K · 5.02Reported a director or officer change (departure, election, appointment or pay arrangement)open
Risks flagged
No material risk; routine board succession.
“Retirement not due to any disagreement; new director is independent.”
17 Feb 202610-KNet sales $7.20B (-3% y/y); Net income attributable to Ingredion $729M (+13% y/y); Operating income $1.02B (+15% y/y)open
Figures in the filing · each found in the filing text
| Net sales · FY2025 | $7.20B | -3% y/y |
| Net income attributable to Ingredion · FY2025 | $729M | +13% y/y |
| Operating income · FY2025 | $1.02B | +15% y/y |
| Gross profit margin · FY2025 | 25.0% | |
| Diluted earnings per share · FY2025 | $11.18 | +15% y/y |
| T&HS net sales · Texture & Healthful Solutions · FY2025 | $2.40B | +1% y/y |
| F&II–LATAM net sales · Food & Industrial Ingredients–LATAM · FY2025 | $2.34B | -4% y/y |
| F&II–U.S./Canada net sales · Food & Industrial Ingredients–U.S./Canada · FY2025 | $2.01B | -7% y/y |
| Effective income tax rate · FY2025 | 24.4% |
Risks flagged
Production disruption risk
“The decrease was primarily driven by lower volumes and production challenges at one of our large manufacturing facilities.” · word for word
Interest rate refinancing risk
“We have senior notes with $499 million principal, net of discounts, which incur interest at 3.2 percent annually, that mature on October 1, 2026. If we are unable to secure refinancing of these notes at a favorable interest rate, our financial results and cash flows could be adversely affected.” · word for word
11 Feb 20268-K · 8.01Disclosed a material event under other events (litigation, recall, contract loss, or major announcement)open
Risks flagged
Potential governance risk from CEO duality, partially mitigated by independent Lead Director role.
“CEO appointed Chairman; independent directors elected Lead Director to serve as liaison.”
3 Feb 20268-K · 2.02Reported diluted EPS $11.18 (+15% y/y); Adjusted diluted EPS $11.13 (+4% y/y); Cash from operations $944M; Guidance: FY2026 adj. EPS guidance $11.00-$11.80 vs FY2025 adj. EPS $11.13earningsopen
Figures in the filing · each found in the filing text
| Reported diluted EPS · FY2025 | $11.18 | +15% y/y |
| Adjusted diluted EPS · FY2025 | $11.13 | +5% y/y |
| Cash from operations · FY2025 | $944M | |
| Net sales · FY2025 | $7.22B | -3% y/y |
| Adjusted operating income · FY2025 | $1.03B | +1% y/y |
| Share repurchases · FY2025 | $224M |
Guidance
FY2026 adj. EPS guidance $11.00-$11.80 vs FY2025 adj. EPS $11.13
FY2026 EPS guidance range implies potential growth from FY2025 record levels, with management expressing confidence in T&HS momentum and F&II recovery.
Risks flagged
Operational challenges in F&II U.S./CAN segment and weaker sweetener demand due to higher retail prices for canned beverages.
“In Food & Industrial Ingredients–U.S./CAN, operational challenges combined with weaker sweetener demand, driven primarily by higher retail prices for canned beverages, impacted results.” · word for word
27 Jan 20268-K · 5.02Reported a director or officer change (departure, election, appointment or pay arrangement)open
Risks flagged
Transition risk from CFO departure; potential disruption in financial oversight until successor is named.
“CFO retiring; succession plan under review; no successor announced.”
7 Nov 202510-QQ3 2025 net sales decreased 3% to $1,816M, gross margin contracted to 25%, net income down 9% to $171M; T&HS segment showed growth.earningsopen
Figures in the filing · each found in the filing text
| Net Sales · Q3-2025 | $1.82B | -3% y/y |
| Gross Margin · Q3-2025 | 25.0% | |
| Net Income · Q3-2025 | $171M | -9% y/y |
| Adjusted Operating Income - T&HS · Texture & Healthful Solutions · Q3-2025 | $105M | +9% y/y |
| Adjusted Operating Income - F&II LATAM · Food & Industrial Ingredients – LATAM · Q3-2025 | $116M | -12% y/y |
| Adjusted Operating Income - F&II U.S./Canada · Food & Industrial Ingredients – U.S./Canada · Q3-2025 | $81M | -18% y/y |
| Operating Cash Flow · 9M-2025 | $539M | -46% y/y |
| Capital Expenditures · 9M-2025 | $298M | +75% y/y |
| Share Repurchases · 9M-2025 | $134M | +54% y/y |
Guidance
Capital expenditure guidance $400M-$425M for FY2025
No revenue or earnings guidance provided; capex guidance reaffirmed at $400M-$425M for FY2025.
Risks flagged
Production Challenges at Manufacturing Facility
“The decrease resulted primarily from continued production challenges at one of our large manufacturing facilities and lower beverage and food industry volume demand.” · word for word
Tariff and Trade Policy Uncertainty
“We continue to monitor changing tariff requirements and reciprocal actions, as well as indirect effects in the economic environment, which may adversely affect our operations, although these factors have had an immaterial impact on our results for year-to-date 2025.” · word for word
Raw Material Price Volatility
“price fluctuations, supply chain disruptions, tariffs, duties and shortages affecting inputs to our procurement, production processes and delivery channels, including raw materials, energy costs and availability and cost of freight and logistics” · word for word
4 Nov 20258-K · 2.02Reported Diluted EPS $2.61 (-8% y/y); Adjusted Diluted EPS $2.75 (-10% y/y); Reported Operating Income $249M (-7% y/y); Guidance: Adjusted EPS guidance $11.10-$11.30 (from prior $11.30-$11.50 implied)earningsopen
Figures in the filing · each found in the filing text
| Reported Diluted EPS · Q3-2025 | $2.61 | -8% y/y |
| Adjusted Diluted EPS · Q3-2025 | $2.75 | -10% y/y |
| Reported Operating Income · Q3-2025 | $249M | -7% y/y |
| Adjusted Operating Income · Q3-2025 | $254M | -10% y/y |
| Texture & Healthful Solutions Segment Operating Income · Texture & Healthful Solutions · Q3-2025 | $105M | +9% y/y |
| Food & Industrial Ingredients – LATAM Segment Operating Income · Food & Industrial Ingredients – LATAM · Q3-2025 | $116M | -11% y/y |
Guidance
Adjusted EPS guidance $11.10-$11.30 (from prior $11.30-$11.50 implied)
Full-year adjusted EPS guidance lowered; reflects operational challenges and softer demand.
Risks flagged
Operational challenges at Chicago plant; softer consumer demand in LATAM and U.S./Canada; brewing industry weakness
“Ongoing production challenges at Chicago plant following fire; reduced consumer beverage and food demand; weaker brewing industry demand in LATAM.”
Ingredion Incorporated — questions
- What did Ingredion Incorporated file recently?
- 23 SEC filings in the last 12 months. Latest: 8-K on 2026-08-20 — Reported a director or officer change (departure, election, appointment or pay arrangement)
Every figure on this page comes from Ingredion Incorporated's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.